Core Viewpoint - National plaintiffs' law firm Berger Montague PC is investigating potential claims on behalf of investors in Northern Dynasty Minerals Ltd. regarding possible violations of federal securities laws or other unlawful conduct by the company and its senior management [1]. Company Overview - Northern Dynasty Minerals Ltd. is headquartered in Vancouver, BC, and is involved in the exploration of mineral properties, including deposits of copper, gold, molybdenum, silver, and rhenium [2]. Legal and Regulatory Developments - On February 17, 2026, the U.S. Department of Justice supported the U.S. Environmental Protection Agency's veto of Northern Dynasty's proposed Pebble Mine in Southwest Alaska [2]. - Following this news, Northern Dynasty's shares dropped by $0.80, representing a decline of more than 39%, closing at $1.23 per share on February 18, 2026 [3].

Core Viewpoint - Gemini Crypto is facing a class-action lawsuit from shareholders who allege that the company misled investors during its September IPO regarding its business model and growth strategy [1][4][8] Group 1: Lawsuit Allegations - The lawsuit claims that Gemini raised capital under the pretense of a growth story but quickly shifted focus to prediction markets and cost-cutting after the IPO [1][5] - Shareholders assert that the company’s narrative changed significantly from its IPO pitch, which emphasized global expansion and user growth, to a sudden pivot towards prediction markets and workforce reduction [4][5] - The plaintiffs argue that this shift was a premeditated strategy rather than a reaction to market conditions, making the IPO materials misleading from the outset [5][7] Group 2: Stock Performance - Gemini's stock price experienced a dramatic decline, falling from a post-IPO high of $40 to around $6, representing an 80% collapse [2][8] - This significant drop in stock value has prompted investors to seek answers regarding the company's business practices and disclosures [2][8] Group 3: Regulatory Context - The regulatory environment poses challenges for Gemini, as the lawsuit involves securities law, which does not accommodate sentiment and focuses on the accuracy of disclosures made to investors [7] - The lawsuit differs from previous legal issues related to unregistered securities, as it questions whether investors were misled about a business model that was already being abandoned [7]

Core Viewpoint - Marex Group PLC is facing a class action lawsuit for allegedly misleading investors about its revenue projections and inflating its financial metrics through improper accounting practices [1][2]. Group 1: Company Overview - Marex Group PLC is a U.K.-based diversified global financial services platform [1]. Group 2: Legal Allegations - The lawsuit claims that Marex Group failed to disclose that it improperly inflated its cash flow, revenues, assets, and profits of its Market Making segment through off-book intercompany transactions [2]. - As a result of these alleged actions, class members have reportedly suffered significant losses and damages [2]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action against Marex Group PLC, with a deadline to submit papers to serve as lead plaintiff by December 8, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Group 4: Legal Representation - Robbins LLP is leading the class action, operating on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is successful [4].

Core Viewpoint - Reed's, Inc. has successfully closed a PIPE financing transaction, raising $5.0 million through the sale of 5,000,000 shares at $1.00 per share, aimed at enhancing working capital and supporting growth initiatives [1][2]. Group 1: Financing Details - The PIPE financing closed on September 15, 2025, generating gross proceeds of $5.0 million [1]. - The company sold 5,000,000 shares of common stock at a price of $1.00 per share [1]. Group 2: Strategic Intent - The proceeds from the financing will be used for working capital and general corporate purposes, allowing the company to invest in personnel, marketing, and product innovation [2]. - The CEO emphasized that the enhanced working capital position will provide greater flexibility to strengthen brand presence and expand market share [2]. Group 3: Leadership Changes - Michael Tu has been appointed to the Board of Directors as a corporate governance advisor and securities litigation expert, effective September 15, 2025, replacing Lee Edwards [2][3]. - Mr. Tu brings nearly three decades of experience in corporate governance and securities law, having previously worked as a partner at Orrick and Cooley [3]. Group 4: Company Overview - Reed's, Inc. is a leader in handcrafted, natural ginger beverages, with a portfolio that includes ginger beers, ginger ales, and a new functional soda line [5][6]. - The company was established in 1989 and its beverages are sold in over 32,000 stores nationwide [5].

Regulatory Changes - Japan regulator proposes crypto rule changes to align with securities law [1] Industry Focus - The proposed changes focus on cryptocurrency regulations [1]

Core Viewpoint - The complaint against Biohaven alleges violations of federal securities laws due to misleading statements regarding the regulatory prospects of its drug troriluzole for spinocerebellar ataxia (SCA) and BHV-7000 for bipolar disorder, which could significantly impact the company's business and financial condition [2]. Group 1 - Biohaven's stock price fell by $3.84 per share, or 19.53%, closing at $15.82 per share following the announcement of an extended PDUFA date for the troriluzole NDA, indicating market reaction to regulatory uncertainties [3]. - The FDA extended the PDUFA date for the troriluzole NDA by three months to allow for a full review of recent submissions, and an advisory committee meeting is planned but not yet scheduled [3]. Group 2 - The lead plaintiff in the class action is the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [4]. - Any member of the putative class can move to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [4]. Group 3 - Faruqi & Faruqi, LLP is encouraging individuals with information regarding Biohaven's conduct to come forward, including whistleblowers and former employees [5].